ZA896372B - Vaccine - Google Patents

Vaccine

Info

Publication number
ZA896372B
ZA896372B ZA896372A ZA896372A ZA896372B ZA 896372 B ZA896372 B ZA 896372B ZA 896372 A ZA896372 A ZA 896372A ZA 896372 A ZA896372 A ZA 896372A ZA 896372 B ZA896372 B ZA 896372B
Authority
ZA
South Africa
Prior art keywords
vaccine
Prior art date
Application number
ZA896372A
Other languages
English (en)
Inventor
Donald Norman Black
Norman Black Donald
Christopher John Bostock
John Bostock Christopher
Paul David Gershon
David Gershon Paul
Original Assignee
Animal Health Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Animal Health Inst filed Critical Animal Health Inst
Publication of ZA896372B publication Critical patent/ZA896372B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/60—Vector systems having a special element relevant for transcription from viruses

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ZA896372A 1988-08-20 1989-08-21 Vaccine ZA896372B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8819836A GB2222165B (en) 1988-08-20 1988-08-20 Recombinant capripoxvirus

Publications (1)

Publication Number Publication Date
ZA896372B true ZA896372B (en) 1990-07-25

Family

ID=10642474

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA896372A ZA896372B (en) 1988-08-20 1989-08-21 Vaccine

Country Status (6)

Country Link
EP (1) EP0432196A1 (de)
AU (1) AU621934B2 (de)
GB (1) GB2222165B (de)
OA (1) OA09636A (de)
WO (1) WO1990002190A1 (de)
ZA (1) ZA896372B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5833975A (en) * 1989-03-08 1998-11-10 Virogenetics Corporation Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence
US7767449B1 (en) 1981-12-24 2010-08-03 Health Research Incorporated Methods using modified vaccinia virus
US5174993A (en) * 1981-12-24 1992-12-29 Health Research Inc. Recombinant avipox virus and immunological use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2602790B1 (fr) * 1986-08-13 1990-06-01 Transgene Sa Expression d'un antigene specifique de tumeur par un virus vecteur recombinant et utilisation de celui-ci pour le traitement preventif ou curatif de la tumeur correspondante
WO1988002022A1 (en) * 1986-09-22 1988-03-24 Commonwealth Scientific And Industrial Research Or Recombinant poxviruses
EP0261940A3 (de) * 1986-09-23 1989-07-05 Applied Biotechnology, Inc. Pseudorabies-Impfstoffe und DNS-Vektoren zur Rekombination mit Poxviren

Also Published As

Publication number Publication date
OA09636A (en) 1993-04-30
GB8819836D0 (en) 1988-09-21
AU621934B2 (en) 1992-03-26
WO1990002190A1 (en) 1990-03-08
AU4190989A (en) 1990-03-23
GB2222165A (en) 1990-02-28
EP0432196A1 (de) 1991-06-19
GB2222165B (en) 1992-06-17

Similar Documents

Publication Publication Date Title
GB8907914D0 (en) Vaccine preparation
EP0391997A4 (en) Vaccine
EP0256878A3 (en) Vaccines
GB8921470D0 (en) Vaccines
ZA88149B (en) Anti-reproductive vaccines
KR970007376B1 (en) Coccidiosis vaccine
GB8702691D0 (en) Vaccines
ZW22487A1 (en) Vaccine
GB8815560D0 (en) Improved last
ZA874847B (en) Oncornavirus vaccines
GB8704647D0 (en) Vaccine
ZA896372B (en) Vaccine
GB8615068D0 (en) Vaccines
GB8912496D0 (en) Vaccines
EP0453452A4 (en) Vaccine
IE882054L (en) Vaccine
GB8805603D0 (en) Vaccine
IE880831L (en) Vaccines
GB8810807D0 (en) Vaccines
GB8804688D0 (en) Vaccines
GB8605646D0 (en) Vaccines
GB8922651D0 (en) Vaccine
GB8712685D0 (en) Vaccine
IE892784L (en) Vaccines
GB8926832D0 (en) Vaccines